SS Innovations International Inc. (NASDAQ: SSII) is broadening its global presence in the rapidly growing surgical robotics market, leveraging its proprietary SSi Mantra robotic surgery platform to address the demand for minimally invasive procedures. The company has installed more than 200 SSi Mantra systems worldwide, which have supported over 12,000 robotic procedures across more than 170 surgical indications, according to a recent announcement.
The company’s strategy emphasizes affordability, physician training, and international expansion, distinguishing it from competitors focused primarily on premium hospital systems. By reducing acquisition and operating costs, SS Innovations aims to enable more hospitals to introduce robotic-assisted procedures without the high financial barriers often associated with such technology. The SSi Mantra platform also includes telesurgery capabilities, which could further expand access to surgical expertise in remote or underserved areas.
SS Innovations is actively pursuing U.S. FDA clearance and European regulatory approvals while continuing to build its installed base internationally. The growing demand for minimally invasive surgery and broader access to robotic procedures is creating opportunities for emerging medtech companies like SS Innovations. The market for robotic-assisted surgery continues to evolve as healthcare systems seek technologies that can improve surgical precision while expanding patient access.
For more information, visit the company’s newsroom at https://ibn.fm/SSII. InvestorWire, a specialized communications platform, provided this press release syndication. For details on InvestorWire, see https://www.InvestorWire.com and its disclaimer at https://www.InvestorWire.com/Disclaimer.
